Stateful metadata for big data

Large volumes of data, characterized by large variety and high update velocities, pose challenges in terms of storage, application of concurrently occurring frequent updates, and serving processes that require the most accurate version of the data simultaneously. In most current schemes, it is not possible to guarantee all of these characteristics and a relaxing one or more requirements is necessary. The present disclosure describes a scalable, easy-to-maintain metadata mechanism that is fast and efficient to update, and can provide all the above guarantees on data. The metadata maintains lightweight validity markers, and simple algebra is performed thereof to surface the most up to date and accurate data while enabling constant updates to the data in a non-blocking fashion

A case report on a rare presentation of Aeromonas hydrophila

The genus Aeromonas is a member of the family Vibrionaceae. Aeromonas hydrophila is a water-dwelling, gram-negative rod-shaped bacterium, associated with diarrheal illness and less commonly, bone and soft tissue infections, especially among immunocompromised patients. Here we reported a rare presentation of A. hydrophila causing septicemia, septic arthritis, and osteomyelitis in an immunocompetent patient. A 35-year-old female, known hypothyroidism, presented with low back pain for one and half months and left side hip pain radiating to the left lower limb for one month. While in the hospital, she subsequently developed overwhelming sepsis secondary to septic arthritis and osteomyelitis. Which was secondary to a multidrug-resistant strain of A. hydrophila. Despite broad-spectrum antibiotics and aggressive surgical management, she had a recurrence of the infection. Aeromonas species infection in both immunocompetent and immunocompromised patients may result in high morbidity and mortality. This organism is highly virulent and multidrug-resistant. So early diagnosis and early administration of antibiotics would give better outcomes

Thermo-responsive Fluorescent Nanoparticles for Multimodal Imaging and Treatment of Cancers

Theranostic systems capable of delivering imaging and therapeutic agents at a specific target are the focus of intense research efforts in drug delivery. To overcome non-degradability and toxicity concerns of conventional theranostic systems, we formulated a novel thermo-responsive fluorescent polymer (TFP) and conjugated it on the surface of iron oxide magnetic nanoparticles (MNPs) for imaging and therapeutic applications in solid tumors. Methods: TFP-MNPs were synthesized by copolymerizing poly(N-isopropylacrylamide), allylamine and a biodegradable photoluminescent polymer, and conjugating it on MNPs via a free radical polymerization reaction. Physicochemical properties of the nanoparticles were characterized using Fourier transform infrared spectroscopy, dynamic light scattering, and vibrational sample magnetometry. Nanoparticle cytocompatibility, cellular uptake and cytotoxicity were evaluated using in vitro cell assays. Finally, in vivo imaging and therapeutic efficacy studies were performed in subcutaneous tumor xenograft mouse models. Results: TFP-MNPs of ~135 nm diameter and -31 mV ζ potential maintained colloidal stability and superparamagnetic properties. The TFP shell was thermo-responsive, fluorescent, degradable, and released doxorubicin in response to temperature changes. In vitro cell studies showed that TFP-MNPs were compatible to human dermal fibroblasts and prostate epithelial cells. These nanoparticles were also taken up by prostate and skin cancer cells in a dose-dependent manner and exhibited enhanced killing of tumor cells at 41°C. Preliminary in vivo studies showed theranostic capabilities of the nanoparticles with bright fluorescence, MRI signal, and therapeutic efficacy under magnetic targeting after systemic administration in tumor bearing mice. Conclusion: These results indicate the potential of TFP-MNPs as multifunctional theranostic nanoparticles for various biological applications, including solid cancer management

Parallel Programming with Migratable Objects: Charm++ in Practice

The advent of petascale computing has introduced new challenges (e.g. Heterogeneity, system failure) for programming scalable parallel applications. Increased complexity and dynamism in science and engineering applications of today have further exacerbated the situation. Addressing these challenges requires more emphasis on concepts that were previously of secondary importance, including migratability, adaptivity, and runtime system introspection. In this paper, we leverage our experience with these concepts to demonstrate their applicability and efficacy for real world applications. Using the CHARM++ parallel programming framework, we present details on how these concepts can lead to development of applications that scale irrespective of the rough landscape of supercomputing technology. Empirical evaluation presented in this paper spans many miniapplications and real applications executed on modern supercomputers including Blue Gene/Q, Cray XE6, and Stampede

High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India

<p>Abstract</p> <p>Background</p> <p>The risk for occupational exposure to HIV has been well characterized in the developed world, but limited information is available about this transmission risk in resource-constrained settings facing the largest burden of HIV infection. In addition, the feasibility and utilization of post-exposure prophylaxis (PEP) programs in these settings are unclear. Therefore, we examined the rate and characteristics of occupational exposure to HIV and the utilization of PEP among health care workers (HCW) in a large, urban government teaching hospital in Pune, India.</p> <p>Methods</p> <p>Demographic and clinical data on occupational exposures and their management were prospectively collected from January 2003–December 2005. US Centers for Diseases Control guidelines were utilized to define risk exposures, for which PEP was recommended. Incidence rates of reported exposures and trends in PEP utilization were examined using logistic regression.</p> <p>Results</p> <p>Of 1955 HCW, 557 exposures were reported by 484 HCW with an incidence of 9.5 exposures per 100 person-years (PY). Housestaff, particularly interns, reported the greatest number of exposures with an annual incidence of 47.0 per 100 PY. Personal protective equipment (PPE) was used in only 55.1% of these exposures. The incidence of high-risk exposures was 6.8/100 PY (n = 339); 49.1% occurred during a procedure or disposing of equipment and 265 (80.0%) received a stat dose of PEP. After excluding cases in which the source tested HIV negative, 48.4% of high-risk cases began an extended PEP regimen, of whom only 49.5% completed it. There were no HIV or Hepatitis B seroconversions identified. Extended PEP was continued unnecessarily in 7 (35%) of 20 cases who were confirmed to be HIV-negative. Over time, there was a significant reduction in proportion of percutaneous exposures and high-risk exposures (p < 0.01) and an increase in PEP utilization for high risk exposures (44% in 2003 to 100% in 2005, p = 0.002).</p> <p>Conclusion</p> <p>Housestaff are a vulnerable population at high risk for bloodborne exposures in teaching hospital settings in India. With implementation of a hospital-wide PEP program, there was an encouraging decrease of high-risk exposures over time and appropriate use of PEP. However, overall use of PPE was low, suggesting further measures are needed to prevent occupational exposures in India.</p

[6]センターの行事

Supplementary Methods and Results4.pdf. Supplementary Methods: Survey Administration: Additional details about how the surveys were administered. Supplementary Results: Clinician Feedback: The results of the clinician survey in Additional file 3 show that clinicians perceive higher patient comfort when using a live interpreter. (PDF 61 kb

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy